Management of Skin and Soft-Tissue Infections in the Emergency Department

Eron, 2003, Managing skin and soft tissue infections: expert panel recommendations on key decision points, J Antimicrob Chemother, 52, i3, 10.1093/jac/dkg466 DiNubile, 2004, Complicated infections of skin and skin structures: when the infection is more than skin deep, J Antimicrob Chemother, 53, ii37, 10.1093/jac/dkh202 Center for Drug Evaluation and Research (CDER). Uncomplicated and complicated skin and skin structure infections: developing antimicrobial drugs for treatment. Guidance for industry. Available at: http://www.fda.gov/cder/guidance/2566dft.pdf. Accessed November 20, 2007. Stevens, 2005, Practice guidelines for the diagnosis and management of skin and soft-tissue infections, Clin Infect Dis, 41, 1373, 10.1086/497143 Talan, 1999, Bacteriologic analysis of infected dog and cat bites, N Engl J Med, 340, 85, 10.1056/NEJM199901143400202 Talan, 2003, Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments, Clin Infect Dis, 37, 1481, 10.1086/379331 Moet, 2007, Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004), Diagn Microbiol Infect Dis, 57, 7, 10.1016/j.diagmicrobio.2006.05.009 Rennie, 2003, Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000), Diagn Microbiol Infect Dis, 45, 287, 10.1016/S0732-8893(02)00543-6 Klevens, 2007, Invasive methicillin-resistant Staphylococcus aureus infections in the United States, J Am Med Assoc, 298, 1763, 10.1001/jama.298.15.1763 Frazee, 2005, High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections, Ann Emerg Med, 45, 311, 10.1016/j.annemergmed.2004.10.011 Moran, 2005, Methicillin-resistant Staphylococcus aureus in community-acquired skin infections, Emerg Infect Dis, 11, 928, 10.3201/eid1106.040641 Moran, 2006, Methicillin-resistant S. aureus infections among patients in the emergency department, N Engl J Med, 355, 666, 10.1056/NEJMoa055356 Miller, 2005, Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles, N Engl J Med, 352, 1445, 10.1056/NEJMoa042683 Diep, 2006, Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus, Lancet, 367, 731, 10.1016/S0140-6736(06)68231-7 Voyich, 2006, Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?, J Infect Dis, 194, 1761, 10.1086/509506 Lina, 1999, Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia, Clin Infect Dis, 29, 1128, 10.1086/313461 Vandenesch, 2003, Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence, Emerg Infect Dis, 9, 978, 10.3201/eid0908.030089 Gillet, 2002, Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotizing pneumonia in young immunocompetent patients, Lancet, 359, 753, 10.1016/S0140-6736(02)07877-7 Labandeira-Rey, 2007, Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia, Science, 315, 1130, 10.1126/science.1137165 Wang, 2007, Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA, Nat Med, 13, 1510, 10.1038/nm1656 Miller, 2007, Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation, Clin Infect Dis, 44, 471, 10.1086/511033 Skiest, 2007, Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients, J Infect, 54, 427, 10.1016/j.jinf.2006.09.012 Naimi, 2003, Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection, J Am Med Assoc, 290, 2976, 10.1001/jama.290.22.2976 Gorwitz RJ, Jernigan DB, Powers JH, et al, and Participants in the CDC-Convened Experts' Meeting on Management of MRSA in the Community. Strategies for clinical management of MRSA in the community. Summary of an experts' meeting convened by the Centers for Disease Control and Prevention, 2006. Available at: http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html. Accessed November 20, 2007. Hook, 1986, Microbiologic evaluation of cutaneous cellulitis in adults, Arch Intern Med, 146, 295, 10.1001/archinte.146.2.295 Sigurdsson, 1989, The etiology of bacterial cellulitis as determined by fine-needle aspiration, Scand J Infect Dis, 21, 537, 10.3109/00365548909037882 Sachs, 1990, The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults, Arch Intern Med, 150, 1907, 10.1001/archinte.150.9.1907 Duvanel, 1989, Quantitative cultures of biopsy specimens from cutaneous cellulitis, Arch Intern Med, 149, 293, 10.1001/archinte.149.2.293 Bernard, 1989, Streptococcal cause of erysipelas and cellulitis in adults. A microbiologic study using a direct immunofluorescence technique, Arch Dermatol, 125, 779, 10.1001/archderm.125.6.779 Chartier, 1990, Erysipelas, Int J Dermatol, 29, 459, 10.1111/j.1365-4362.1990.tb04833.x Eriksson, 1996, Erysipelas: clinical and bacteriologic spectrum and serological aspects, Clin Infect Dis, 23, 1091, 10.1093/clinids/23.5.1091 Kielhofner, 1988, Influence of underlying disease process on the utility of cellulitis needle aspirates, Arch Intern Med, 148, 2451, 10.1001/archinte.148.11.2451 Squire, 2005, ABSCESS: applied bedside sonography for convenient evaluation of superficial soft tissue infections, Acad Emerg Med, 12, 601, 10.1111/j.1553-2712.2005.tb00913.x Tayal, 2006, The effect of soft-tissue ultrasound on the management of cellulitis in the emergency department, Acad Emerg Med, 13, 384, 10.1111/j.1553-2712.2006.tb00314.x Wong, 2003, Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality, J Bone Joint Surg Am, 85-A, 1454, 10.2106/00004623-200308000-00005 McHenry, 1995, Determinants of mortality for necrotizing soft-tissue infections, Ann Surg, 221, 558, 10.1097/00000658-199505000-00013 Elhabash, 2007 Summanen, 1995, Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use, Clin Infect Dis, 20, S279, 10.1093/clinids/20.Supplement_2.S279 Anaya, 2007, Necrotizing soft-tissue infection: diagnosis and management, Clin Infect Dis, 44, 705, 10.1086/511638 Elliott, 1996, Necrotizing soft tissue infections. Risk factors for mortality and strategies for management, Ann Surg, 224, 672, 10.1097/00000658-199611000-00011 Green, 1996, Necrotizing fasciitis, Chest, 110, 219, 10.1378/chest.110.1.219 Pannaraj, 2006, Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection, Clin Infect Dis, 43, 953, 10.1086/507637 Dehority, 2006, Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate, Pediatr Infect Dis J, 25, 1080, 10.1097/01.inf.0000243158.25713.29 Wong, 2004, Recurrent necrotizing fasciitis caused by methicillin-resistant Staphylococcus aureus, Eur J Clin Microbiol Infect Dis, 23, 909 Abrahamian, 2007, Use of routine wound cultures to evaluate cutaneous abscesses for community-associated methicillin-resistant Staphylococcus aureus, Ann Emerg Med, 50, 66, 10.1016/j.annemergmed.2006.01.019 Lee, 2004, Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus, Pediatr Infect Dis J, 23, 123, 10.1097/01.inf.0000109288.06912.21 Miller, 2007, A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection, Clin Infect Dis, 44, 483, 10.1086/511041 Rajendran, 2007, Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection, Antimicrobial Agents Chemother, 51, 4044, 10.1128/AAC.00377-07 Perl, 1999, Cost-effectiveness of blood cultures for adult patients with cellulitis, Clin Infect Dis, 29, 1483, 10.1086/313525 Bates, 1991, Contaminant blood cultures and resource utilization. The true consequences of false-positive results, J Am Med Assoc, 265, 365, 10.1001/jama.265.3.365 Swartz, 2004, Cellulitis, N Engl J Med, 350, 904, 10.1056/NEJMcp031807 Nguyen, 2006, Severe sepsis and septic shock: review of the literature and emergency department management guidelines, Ann Emerg Med, 48, 28, 10.1016/j.annemergmed.2006.02.015 Newell, 1988, Value of needle aspiration in bacteriologic diagnosis of cellulitis in adults, J Clin Microbiol, 26, 401, 10.1128/JCM.26.3.401-404.1988 Stamenkovic, 1984, Early recognition of potentially fatal necrotizing fasciitis. The use of frozen-section biopsy, N Engl J Med, 310, 1689, 10.1056/NEJM198406283102601 Majeski, 1997, Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment, South Med J, 90, 1065, 10.1097/00007611-199711000-00001 Ault, 1996, Rapid identification of group A streptococcus as the cause of necrotizing fasciitis, Ann Emerg Med, 28, 227, 10.1016/S0196-0644(96)70065-3 Wong, 2004, The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections, Crit Care Med, 32, 1535, 10.1097/01.CCM.0000129486.35458.7D Fitch, 2007, Abscess incision and drainage, N Engl J Med, 357, e20, 10.1056/NEJMvcm071319 Berg, 2006, Antibacterial properties of EMLA and lidocaine in wound tissue biopsies for culturing, Wound Repair Regen, 14, 581, 10.1111/j.1743-6109.2006.00157.x Ruhe, 2007, Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome, Clin Infect Dis, 44, 777, 10.1086/511872 Fridkin, 2005, Methicillin-resistant Staphylococcus aureus disease in three communities, N Engl J Med, 352, 1436, 10.1056/NEJMoa043252 Betriu, 2001, Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci, J Antimicrob Chemother, 48, 911, 10.1093/jac/48.6.911 Weigelt, 2005, Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections, Antimicrobial Agents Chemother, 49, 2260, 10.1128/AAC.49.6.2260-2266.2005 Carpenter, 2004, Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens, Clin Infect Dis, 38, 994, 10.1086/383472 Stein, 2006, Tigecycline: a critical analysis, Clin Infect Dis, 43, 518, 10.1086/505494 Jones RN, Ballow CH, Acar J, et al. World-wide evaluation of quinupristin-dalfopristin (Q/D) (Synercid): Antimicrobial activity directed against resistant Gram-positive pathogens: Report from the global SMART study. Presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA, 1999. Abstract 1262. p. 263. American Society for Microbiology, Washington, D.C. Drew, 2000, Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy, J Antimicrob Chemother, 46, 775, 10.1093/jac/46.5.775 Nichols, 1999, J Antimicrob Chemother, 44, 263, 10.1093/jac/44.2.263 Jauregui, 2005, Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections, Clin Infect Dis, 41, 1407, 10.1086/497271 Saravolatz, 2007, Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus, J Antimicrob Chemother, 60, 406, 10.1093/jac/dkm211 Van Bambeke, 2004, Glycopeptide antibiotics: from conventional molecules to new derivatives, Drugs, 64, 913, 10.2165/00003495-200464090-00001 Rouse, 2007, In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection, Diagn Microbiol Infect Dis, 58, 363, 10.1016/j.diagmicrobio.2007.02.010 Arpida. Intravenous iclaprim. Available at: http://www.arpida.ch/index.php?MenuID=13&;UserID=1&ContentID=65. Accessed November, 2007. Gilbert, 2007 Bruun, 1981, Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid, Antimicrobial Agents Chemother, 19, 82, 10.1128/AAC.19.1.82 Nowak, 1983, Penetration of trimethoprim and sulfamethoxazole into skin blister fluid, Eur J Clin Pharmacol, 25, 825, 10.1007/BF00542528 Strausbaugh, 1992, Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit, Infect Control Hosp Epidemiol, 13, 151, 10.1086/646499 Iyer, 2004, Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak, J Am Acad Dermatol, 50, 854, 10.1016/j.jaad.2003.12.043 Yu, 1986, Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis, N Engl J Med, 315, 91, 10.1056/NEJM198607103150204 Simor, 2007, Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization, Clin Infect Dis, 44, 178, 10.1086/510392 Stevens, 2007, Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus, J Infect Dis, 195, 202, 10.1086/510396 Siberry, 2003, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro, Clin Infect Dis, 37, 1257, 10.1086/377501 Lewis, 2005, Inducible clindamycin resistance in staphylococci: should clinicians and microbiologists be concerned?, Clin Infect Dis, 40, 280, 10.1086/426894 Frank, 2002, Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children, Pediatr Infect Dis J, 21, 530, 10.1097/00006454-200206000-00010 Panagea, 1999, Should clindamycin be used as treatment of patients with infections caused by erythromycin-resistant staphylococci?, J Antimicrob Chemother, 44, 581, 10.1093/jac/44.4.581 Rao, 2000, Should clindamycin be used in treatment of patients with infections caused by erythromycin-resistant staphylococci?, J Antimicrob Chemother, 45, 715, 10.1093/jac/45.5.715 Drinkovic, 2001, Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance, J Antimicrob Chemother, 48, 315, 10.1093/jac/48.2.315 Martinez-Aguilar, 2003, Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children, Pediatr Infect Dis J, 22, 593, 10.1097/01.inf.0000073163.37519.ee Daum, 2007, Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus, N Engl J Med, 357, 380, 10.1056/NEJMcp070747 Ruhe, 2005, Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature, Clin Infect Dis, 40, 1429, 10.1086/429628 Ruhe, 2007, Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus, Antimicrobial Agents Chemother, 51, 3298, 10.1128/AAC.00262-07 Deresinski, 2007, Vancomycin and Staphylococcus aureus—an antibiotic enters obsolescence, Clin Infect Dis, 44, 1543, 10.1086/518452 Mohr, 2007, Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus, Clin Infect Dis, 44, 1536, 10.1086/518451 Kim, 2008, Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia, Antimicrobial Agents Chemother, 52, 192, 10.1128/AAC.00700-07 Kalil, 2006, Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?, Antimicrobial Agents Chemother, 50, 1910, 10.1128/AAC.50.5.1910-1911.2006 Arbeit, 2004, The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections, Clin Infect Dis, 38, 1673, 10.1086/420818 Ellis-Grosse, 2005, The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam, Clin Infect Dis, 41, S341, 10.1086/431675 Eliopoulos, 1997, In vitro activity of trimethoprim alone compared with trimethoprim-sulfamethoxazole and other antimicrobials against bacterial species associated with upper respiratory tract infections, Diagn Microbiol Infect Dis, 29, 33, 10.1016/S0732-8893(97)00060-6 Bushby, 1973, Trimethoprim-sulfamethoxazole: in vitro microbiological aspects, J Infect Dis, 128, 442, 10.1093/infdis/128.Supplement_3.S442 Trickett, 1973, Clinical experience: respiratory tract. Trimethoprim-sulfamethoxazole versus penicillin G in the treatment of group A beta-hemolytic streptococcal pharyngitis and tonsillitis, J Infect Dis, 128, 693, 10.1093/infdis/128.Supplement_3.S693 Quick, 1975, Comparison of penicillin and trimethoprim-sulfamethoxazole in the treatment of ear, nose and throat infections, Can Med Assoc J, 112, 83 Loeffler, 2005, Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK, J Antimicrob Chemother, 56, 692, 10.1093/jac/dki312 Abrahamian, 2004, Bites, 1440 Stevens, 1995, Antibiotic effects on bacterial viability, toxin production, and host response, Clin Infect Dis, 20, S154, 10.1093/clinids/20.Supplement_2.S154 Stevens, 1987, Effect of antibiotics on toxin production and viability of Clostridium perfringens, Antimicrobial Agents Chemother, 31, 213, 10.1128/AAC.31.2.213 Stevens, 1988, The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis, J Infect Dis, 158, 23, 10.1093/infdis/158.1.23 Zimbelman, 1999, Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection, Pediatr Infect Dis J, 18, 1096, 10.1097/00006454-199912000-00014 Hepburn, 2004, Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis, Arch Intern Med, 164, 1669, 10.1001/archinte.164.15.1669 Carratala, 2003, Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis, Eur J Clin Microbiol Infect Dis, 22, 151, 10.1007/s10096-003-0902-x Benfield, 2007, Influence of diabetes and hyperglycemia on infectious disease hospitalization and outcome, Diabetologia, 50, 549, 10.1007/s00125-006-0570-3 Murray, 2001, Defining treatment failure in ED patients with cellulitis, Acad Emerg Med, 8, 478 Diercks, 2000, Derivation and validation of a model for the need of hospital admission in patients with extremity cellulitis, Acad Emerg Med, 7, 562 Roberts, 2001, Management of patients with infectious diseases in an emergency department observation unit, Emerg Med Clin North Am, 19, 187, 10.1016/S0733-8627(05)70175-9 Corwin, 2005, Randomized controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital, BMJ, 330, 129, 10.1136/bmj.38309.447975.EB Donald, 2005, Emergency department management of home intravenous antibiotic therapy for cellulitis, Emerg Med J, 22, 715, 10.1136/emj.2004.018143 Huletsky, 2005, Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program, Clin Infect Dis, 40, 976, 10.1086/428579 Seybold, 2006, Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections, Clin Infect Dis, 42, 647, 10.1086/499815 Siegel JD, Rhinehart E, Jackson M, et al. Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Available at: www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf. Accessed November 20, 2007. Jones, 2007, Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit, Clin Infect Dis, 45, 541, 10.1086/520663